2022
DOI: 10.1038/s41398-022-02293-2
|View full text |Cite
|
Sign up to set email alerts
|

Placebo and nocebo effects: from observation to harnessing and clinical application

Abstract: Placebo and nocebo effects are salubrious benefits and negative outcomes attributable to non-specific symbolic components. Leveraging advanced experimental and analytical approaches, recent studies have elucidated complicated neural mechanisms that may serve as a solid basis for harnessing the powerful self-healing and self-harming capacities and applying these findings to improve medical practice and minimize the unintended exacerbation of symptoms in medical practice. We review advances in employing psychoso… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(6 citation statements)
references
References 142 publications
0
4
0
Order By: Relevance
“…Since the seminal work of Eisenberger et al (2003 ; for an overview, see Eisenberger (2015) ), many studies reported the activation of part of the affective-motivational component of the pain matrix (i.e., AI and aMCC) when participants experienced or were reminiscent of social pain ( Peyron et al, 2000 ; Eisenberger and Lieberman, 2005 ; Masten et al, 2012 ; Cacioppo et al, 2013 ; Novembre et al, 2015 ; Rotge et al, 2015 ). These regions are those most frequently involved in nociceptive pain elaboration (e.g., Lui et al, 2008 ; for an overview, see Xu et al, 2020 ), including the codification of pain intensity ( Favilla et al, 2014 ), but also in conditions that include pain modulation, observation of painful stimuli, placebo and nocebo, and empathy ( Zaki et al, 2016 ; Zunhammer et al, 2021 ; Tu et al, 2022 ).…”
Section: Discussionmentioning
confidence: 99%
“…Since the seminal work of Eisenberger et al (2003 ; for an overview, see Eisenberger (2015) ), many studies reported the activation of part of the affective-motivational component of the pain matrix (i.e., AI and aMCC) when participants experienced or were reminiscent of social pain ( Peyron et al, 2000 ; Eisenberger and Lieberman, 2005 ; Masten et al, 2012 ; Cacioppo et al, 2013 ; Novembre et al, 2015 ; Rotge et al, 2015 ). These regions are those most frequently involved in nociceptive pain elaboration (e.g., Lui et al, 2008 ; for an overview, see Xu et al, 2020 ), including the codification of pain intensity ( Favilla et al, 2014 ), but also in conditions that include pain modulation, observation of painful stimuli, placebo and nocebo, and empathy ( Zaki et al, 2016 ; Zunhammer et al, 2021 ; Tu et al, 2022 ).…”
Section: Discussionmentioning
confidence: 99%
“…This may occur through multiple pathways that are involved in integrating expectations and sensory information (Geuter et al, 2017). Especially the descending pain modulatory system (DPMS; Geuter et al, 2017; Tu et al, 2022) is associated with placebo and nocebo effects and is thought to consist of areas like the periaqueductal grey (PAG), dorsolateral prefrontal cortex (DLPFC), anterior cingulate cortex (ACC), and amygdala (Eippert et al, 2009), as well as frontal areas like the vmPFC (Geuter et al, 2017; Tu et al, 2022). Further, placebo and nocebo effects modulate activity in areas classically associated with pain processing like the thalamus and the insula during noxious stimulation (Atlas & Wager, 2014; Wager & Atlas, 2015; Wager et al, 2004; Zunhammer et al, 2021).…”
Section: Introductionmentioning
confidence: 99%
“…However, even though the relationship between th placebo effect (positive expectations) in clinical interventions was widely investigated, there were not enough studies on negative expectations (nocebo effect). [ 21 ] Accordingly, we attempted to close this research gap by studying the different aspects of negative expectations in clinical interventions and providing materials to improve. The aim of the present study is to investigate the effects of the negative expectations in therapeutic interventions and how negative expectations or in other words the nocebo responses affect the therapeutic results.…”
Section: Introductionmentioning
confidence: 99%